{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:21:53Z","timestamp":1791328913089,"version":"4.3.1"},"reference-count":50,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.1210\/me.2004-0537","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T02:53:52Z","timestamp":1110509632000},"page":"1460-1473","source":"Crossref","is-referenced-by-count":92,"title":["The Ligand-Dependent Interaction of Mineralocorticoid Receptor with Coactivator and Corepressor Peptides Suggests Multiple Activation Mechanisms"],"prefix":"10.1210","volume":"19","author":[{"given":"Monica L.","family":"Hultman","sequence":"first","affiliation":[{"name":"St. Louis Laboratories, Biological Sciences, Pfizer Global Research & Development, St. Louis, Missouri 63017"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliia V.","family":"Krasnoperova","sequence":"additional","affiliation":[{"name":"St. Louis Laboratories, Biological Sciences, Pfizer Global Research & Development, St. Louis, Missouri 63017"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzhen","family":"Li","sequence":"additional","affiliation":[{"name":"St. Louis Laboratories, Biological Sciences, Pfizer Global Research & Development, St. Louis, Missouri 63017"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Du","sequence":"additional","affiliation":[{"name":"St. Louis Laboratories, Biological Sciences, Pfizer Global Research & Development, St. Louis, Missouri 63017"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunsheng","family":"Xia","sequence":"additional","affiliation":[{"name":"St. Louis Laboratories, Biological Sciences, Pfizer Global Research & Development, St. Louis, Missouri 63017"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica D.","family":"Dietz","sequence":"additional","affiliation":[{"name":"St. Louis Laboratories, Biological Sciences, Pfizer Global Research & Development, St. Louis, Missouri 63017"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak S.","family":"Lala","sequence":"additional","affiliation":[{"name":"St. Louis Laboratories, Biological Sciences, Pfizer Global Research & Development, St. Louis, Missouri 63017"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean J.","family":"Welsch","sequence":"additional","affiliation":[{"name":"St. Louis Laboratories, Biological Sciences, Pfizer Global Research & Development, St. Louis, Missouri 63017"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Hu","sequence":"additional","affiliation":[{"name":"St. Louis Laboratories, Biological Sciences, Pfizer Global Research & Development, St. Louis, Missouri 63017"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041123593057300_R1","first-page":"E96","article-title":"Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S\/JR rats.","volume":"262","author":"Gomez-Sanchez","year":"1992","journal-title":"Am J Physiol"},{"key":"2019041123593057300_R2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1471-4892(01)00022-4","article-title":"Recent studies with eplerenone, a novel selective aldosterone receptor antagonist.","volume":"1","author":"McMahon","year":"2001","journal-title":"Curr Opin Pharmacol"},{"key":"2019041123593057300_R3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1358\/dot.2004.40.6.850481","article-title":"Eplerenone: a new selective aldosterone receptor antagonist.","volume":"40","author":"Weinberger","year":"2004","journal-title":"Drugs Today (Barc)"},{"key":"2019041123593057300_R4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/01.HYP.0000025146.19104.FE","article-title":"Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients.","volume":"40","author":"Krum","year":"2002","journal-title":"Hypertension"},{"key":"2019041123593057300_R5","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"2019041123593057300_R6","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/01.HYP.0000067463.13172.EA","article-title":"Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension.","volume":"41","author":"White","year":"2003","journal-title":"Hypertension"},{"key":"2019041123593057300_R7","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.amjcard.2004.01.007","article-title":"Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension.","volume":"93","author":"Williams","year":"2004","journal-title":"Am J Cardiol"},{"key":"2019041123593057300_R8","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"2019041123593057300_R9","first-page":"E649","article-title":"ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension.","volume":"258","author":"Gomez-Sanchez","year":"1990","journal-title":"Am J Physiol"},{"key":"2019041123593057300_R10","first-page":"E883","article-title":"The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis.","volume":"271","author":"Young","year":"1996","journal-title":"Am J Physiol"},{"key":"2019041123593057300_R11","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1046\/j.1523-1755.2000.00975.x","article-title":"Aldosterone and mineralocorticoid receptors: orphan questions.","volume":"57","author":"Funder","year":"2000","journal-title":"Kidney Int"},{"key":"2019041123593057300_R12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1043-2760(01)00527-6","article-title":"Nuclear receptor coregulators: multiple modes of modification.","volume":"13","author":"Hermanson","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"2019041123593057300_R13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/42750","article-title":"A signature motif in transcriptional co-activators mediates binding to nuclear receptors.","volume":"387","author":"Heery","year":"1997","journal-title":"Nature"},{"key":"2019041123593057300_R14","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1101\/gad.12.21.3343","article-title":"Structure and specificity of nuclear receptor-coactivator interactions.","volume":"12","author":"Darimont","year":"1998","journal-title":"Genes Dev"},{"key":"2019041123593057300_R15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/mend.12.2.0065","article-title":"Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities.","volume":"12","author":"Ding","year":"1998","journal-title":"Mol Endocrinol"},{"key":"2019041123593057300_R16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/47069","article-title":"The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors.","volume":"402","author":"Hu","year":"1999","journal-title":"Nature"},{"key":"2019041123593057300_R17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/emboj\/17.1.232","article-title":"Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor.","volume":"17","author":"Kalkhoven","year":"1998","journal-title":"EMBO J"},{"key":"2019041123593057300_R18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1210\/mend.15.2.0595","article-title":"Two distinct nuclear receptor-interaction domains and CREB-binding protein-dependent transactivation function of activating signal cointegrator-2.","volume":"15","author":"Lee","year":"2001","journal-title":"Mol Endocrinol"},{"key":"2019041123593057300_R19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","article-title":"A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis.","volume":"92","author":"Puigserver","year":"1998","journal-title":"Cell"},{"key":"2019041123593057300_R20","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1074\/jbc.C100631200","article-title":"Peroxisome proliferator-activated receptor \u03b3 coactivator 1\u03b2 (PGC-1\u03b2), a novel PGC-1-related transcription coactivator associated with host cell factor.","volume":"277","author":"Lin","year":"2002","journal-title":"J Biol Chem"},{"key":"2019041123593057300_R21","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1074\/jbc.273.20.12101","article-title":"The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors.","volume":"273","author":"Onate","year":"1998","journal-title":"J Biol Chem"},{"key":"2019041123593057300_R22","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1046\/j.1523-1755.2000.00958.x","article-title":"Mechanistic aspects of mineralocorticoid receptor activation.","volume":"57","author":"Hellal-Levy","year":"2000","journal-title":"Kidney Int"},{"key":"2019041123593057300_R23","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1046\/j.1523-1755.2000.00977.x","article-title":"Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues.","volume":"57","author":"Morris","year":"2000","journal-title":"Kidney Int"},{"key":"2019041123593057300_R24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0303-7207(02)00413-6","article-title":"Interdomain interactions in the mineralocorticoid receptor.","volume":"200","author":"Rogerson","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"2019041123593057300_R25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nsb0196-87","article-title":"A canonical structure for the ligand-binding domain of nuclear receptors.","volume":"3","author":"Wurtz","year":"1996","journal-title":"Nat Struct Biol"},{"key":"2019041123593057300_R26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1126\/science.289.5476.119","article-title":"Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy.","volume":"289","author":"Geller","year":"2000","journal-title":"Science"},{"key":"2019041123593057300_R27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.mce.2003.10.053","article-title":"Identification of steroid ligands able to inactivate the mineralocorticoid receptor harboring the S810L mutation responsible for a severe form of hypertension.","volume":"217","author":"Pinon","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"2019041123593057300_R28","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/endo.141.6.7489","article-title":"Differential expression and regional distribution of steroid receptor coactivators SRC-1 and SRC-2 in brain and pituitary.","volume":"141","author":"Meijer","year":"2000","journal-title":"Endocrinology"},{"key":"2019041123593057300_R29","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1126\/science.279.5358.1922","article-title":"Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene.","volume":"279","author":"Xu","year":"1998","journal-title":"Science"},{"key":"2019041123593057300_R30","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1128\/MCB.22.16.5923-5937.2002","article-title":"The function of TIF2\/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p\/CIP.","volume":"22","author":"Gehin","year":"2002","journal-title":"Mol Cell Biol"},{"key":"2019041123593057300_R31","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1210\/endo.143.4.8828","article-title":"Thyroid function in mice with compound heterozygous and homozygous disruptions of SRC-1 and TIF-2 coactivators: evidence for haploinsufficiency.","volume":"143","author":"Weiss","year":"2002","journal-title":"Endocrinology"},{"key":"2019041123593057300_R32","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1073\/pnas.120166297","article-title":"The steroid receptor coactivator SRC-3 (p\/CIP\/RAC3\/AIB1\/ACTR\/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development.","volume":"97","author":"Xu","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041123593057300_R33","doi-asserted-by":"crossref","first-page":"9424","DOI":"10.1073\/pnas.95.16.9424","article-title":"Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism.","volume":"95","author":"Berger","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041123593057300_R34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1043-2760(01)00457-X","article-title":"PGC-1, a versatile coactivator.","volume":"12","author":"Knutti","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"2019041123593057300_R35","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1172\/JCI10268","article-title":"Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis.","volume":"106","author":"Lehman","year":"2000","journal-title":"J Clin Invest"},{"key":"2019041123593057300_R36","doi-asserted-by":"crossref","first-page":"38911","DOI":"10.1074\/jbc.M103984200","article-title":"Alteration of cardiac and renal functions in transgenic mice overexpressing human mineralocorticoid receptor.","volume":"276","author":"Le Menuet","year":"2001","journal-title":"J Biol Chem"},{"key":"2019041123593057300_R37","doi-asserted-by":"crossref","first-page":"34283","DOI":"10.1074\/jbc.274.48.34283","article-title":"A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo.","volume":"274","author":"Lee","year":"1999","journal-title":"J Biol Chem"},{"key":"2019041123593057300_R38","doi-asserted-by":"crossref","first-page":"45356","DOI":"10.1074\/jbc.C200509200","article-title":"Deletion of the cancer-amplified coactivator AIB3 results in defective placentation and embryonic lethality.","volume":"277","author":"Kuang","year":"2002","journal-title":"J Biol Chem"},{"key":"2019041123593057300_R39","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1128\/MCB.23.4.1260-1268.2003","article-title":"Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction.","volume":"23","author":"Antonson","year":"2003","journal-title":"Mol Cell Biol"},{"key":"2019041123593057300_R40","doi-asserted-by":"crossref","first-page":"8409","DOI":"10.1128\/MCB.22.24.8409-8414.2002","article-title":"Multiple developmental defects derived from impaired recruitment of ASC-2 to nuclear receptors in mice: implication for posterior lenticonus with cataract.","volume":"22","author":"Kim","year":"2002","journal-title":"Mol Cell Biol"},{"key":"2019041123593057300_R41","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0092-8674(00)00188-4","article-title":"Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.","volume":"103","author":"Shang","year":"2000","journal-title":"Cell"},{"key":"2019041123593057300_R42","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1210\/mend.16.4.0798","article-title":"The amino terminus of the human AR is target for corepressor action and antihormone agonism.","volume":"16","author":"Dotzlaw","year":"2002","journal-title":"Mol Endocrinol"},{"key":"2019041123593057300_R43","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/MCB.18.3.1369","article-title":"The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor.","volume":"18","author":"Wagner","year":"1998","journal-title":"Mol Cell Biol"},{"key":"2019041123593057300_R44","doi-asserted-by":"crossref","first-page":"26238","DOI":"10.1074\/jbc.M203268200","article-title":"RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding.","volume":"277","author":"Schulz","year":"2002","journal-title":"J Biol Chem"},{"key":"2019041123593057300_R45","first-page":"359","article-title":"Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism.","volume":"9","author":"Shiau","year":"2002","journal-title":"Nat Struct Biol"},{"key":"2019041123593057300_R46","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1530\/eje.0.1460789","article-title":"Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor.","volume":"146","author":"Quinkler","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"2019041123593057300_R47","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1128\/MCB.22.11.3698-3706.2002","article-title":"Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex.","volume":"22","author":"Kitagawa","year":"2002","journal-title":"Mol Cell Biol"},{"key":"2019041123593057300_R48","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1126\/science.1068537","article-title":"Molecular determinants for the tissue specificity of SERMs.","volume":"295","author":"Shang","year":"2002","journal-title":"Science"},{"key":"2019041123593057300_R49","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1073\/pnas.122225699","article-title":"Coactivator\/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486.","volume":"99","author":"Liu","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041123593057300_R50","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1073\/pnas.95.6.2973","article-title":"Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists.","volume":"95","author":"Fejes-Toth","year":"1998","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/19\/6\/1460\/10718178\/mend1460.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T18:54:29Z","timestamp":1555095269000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/19\/6\/1460\/2737919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,1]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2004-0537","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,1]]}}}